Connect with us
Zolgensma, Novartis' gene therapy for SMA, remains the world's most expensive medicine, priced between $1.2 million and $2.1 million per dose. Despite its high cost, it's...
Spinal muscular atrophy is a rare disease caused by an alteration in the SMN1 gene which leads to progressive muscle weakness, as the lack of SMN...